NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive: As shown in Figure 5, CML and pentosidine at 2–16 μmol/L increased NF-κB p50/65 DNA binding activity in A549 and Calu-6 cells (p < 0.05).